Overview

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

Status:
Completed
Trial end date:
2018-11-03
Target enrollment:
Participant gender:
Summary
A prospective, non-controlled, international, multi-centre phase 3 study to investigate the pharmacokinetics, efficacy, safety, and immunogenicity of Wilate in previously treated children with severe haemophilia A
Phase:
Phase 3
Details
Lead Sponsor:
Octapharma